Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
about
Probing the putative active site of YjdL: an unusual proton-coupled oligopeptide transporter from E. coli.Analysing the substrate multispecificity of a proton-coupled oligopeptide transporter using a dipeptide library.Glycans in the intestinal peptide transporter PEPT1 contribute to function and protect from proteolysis.Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery.Biomedical applications of dipeptides and tripeptides.Accurate Prediction of Ligand Affinities for a Proton-Dependent Oligopeptide Transporter.The dipeptide H-Trp-Arg-OH (WR) Is a PPARα agonist and reduces hepatic lipid accumulation in lipid-loaded H4IIE cells.Effect of Janus kinase 3 on the peptide transporters PEPT1 and PEPT2.New insights into the substrate specificities of proton-coupled oligopeptide transporters from E. coli by a pH sensitive assay.Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future
P2860
Q31105931-6011189E-68DF-4883-BA79-862D3E89ABC7Q34995844-ED6A5042-EBDE-48C0-A1A4-57733FF7133DQ36321216-424856AD-8B04-4949-B72B-20D9CF7A3A87Q36700240-C1F3CA38-F4C1-472F-BCD7-611552E7D35CQ37824864-554B1C85-DFC7-47F8-B0D9-FF945D941DE0Q38063507-02C506B0-6044-4095-90D1-9CCACBF00B85Q38569080-825A2BA1-8FCC-40E3-AADA-5751A5C69661Q38942125-55E7A8EA-850E-4530-AD19-5331494776EEQ44028421-7BC271D8-5687-4103-9C2C-CCDA4120BF88Q54296679-5A389DE0-DD3D-491B-88D7-51670C502E67Q57158690-F6241C04-0018-4517-8168-9AF64B4DBCEB
P2860
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@ast
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@en
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@nl
type
label
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@ast
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@en
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@nl
prefLabel
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@ast
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@en
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@nl
P2093
P2860
P1476
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.
@en
P2093
David Meredith
David W Foley
Jeyaganesh Rajamanickam
Patrick D Bailey
P2860
P356
10.2174/157340910790980133
P577
2010-03-01T00:00:00Z